Observational Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Sep 28, 2020; 26(36): 5498-5507
Published online Sep 28, 2020. doi: 10.3748/wjg.v26.i36.5498
Table 1 Demographics, clinical characteristics and laboratory values of patients in the percutaneous transhepatic gallbladder drainage and percutaneous transperitoneal gallbladder drainage groups, n (%)
PHGD group, n = 58PPGD group, n = 45P value
Age73.8 ± 11.674.8 ± 12.20.672
Sex, male/female31/2724/210.991
BMI in kg/m222.8 ± 0.623.1 ± 0.80.320
Comorbidity, n (%)49 (84.5)41 (91.1)0.315
Hypertension29 (50.0)27 (60.0)0.312
Diabetes26 (44.8)16 (35.6)0.342
Arrhythmia4 (6.9)4 (8.9)0.997
CHD21 (36.2)16 (35.6)0.946
COPD3 (5.2)4 (8.9)0.427
CI9 (15.5)6 (13.3)0.755
CRI1 (1.7)1 (2.2)> 0.999
Others10 (17.2)6 (13.3)0.105
Previous abdominal surgery, n (%)10 (17.2)7 (15.6)0.819
Appendectomy3 (5.2)2 (4.4)> 0.999
Cesarean6 (10.3)3 (6.7)0.699
Oophorectomy1 (1.7)2 (4.4)0.823
ASA grade average2.3 ± 0.42.3 ± 0.50.872
Tokyo Guidelines 20180.918
Grade I5 (8.6)3 (5.2)
Grade II46 (79.3)37 (82.2)
Grade III7 (12.1)5 (11.1)
Body temperature in °C37.4 ± 0.8737.4 ± 0.900.506
Positive Murphy’s sign, n (%)40 (69.0)34 (75.6)0.461
Leukocytes counts ,×109/L15.8 ± 3.215.9 ± 3.00.872
PLT, ×106/L241.7 ± 70.2238.2 ± 68.30.800
ALT, U/L53.2 ± 17.951.2 ± 18.30.579
AST, U/L60.0 ± 18.953.2 ± 20.00.080
TB, μmol/L45.2 ± 24.647.8 ± 24.90.598
PT in s13.9 ± 2.014.1 ± 2.20.631
INR1.2 ± 0.21.3 ± 0.30.045a
Gallbladder size in cm10.6 ± 2.010.8 ± 2.20.631
Gallbladder wall thickness in mm6.6 ± 2.26.9 ± 2.30.503
Duration from onset to PC in h62.4 ± 11.557.6 ± 12.20.043 a
Interval from PC to elective LC in d34.5 ± 4.733.9 ± 4.20.503